Remote ischemic conditioning after aneurysm clipping for ruptured brain aneurysms
Official title: Remote Ischemic Conditioning for Safety, Feasibility, and Preliminary Efficacy in Patients With Aneurysmal Subarachnoid Hemorrhage After Aneurysm Clipping: An Open-Label, Evaluator-Blinded Randomized Controlled Trial
Run by Beijing Tiantan Hospital · NCT06819657 · Data updated 2026-11-12
This test tries brief cycles of limb cuff inflation (remote ischemic conditioning) to see if it is safe and helps recovery in adults after surgical clipping of a ruptured brain aneurysm (aneurysmal subarachnoid hemorrhage).
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | March 10, 2025 |
| Main results expected | December 30, 2025 |
| Study ends | March 30, 2026 |
| Registry record updated | September 9, 2025 |
| Trial ID | NCT06819657 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 with imaging-confirmed aneurysmal subarachnoid hemorrhage who underwent craniotomy clipping within 24 hours and can provide informed consent (or have a legally authorized representative) are ideal candidates.
✕Probably not a fit
Patients with other types of cerebral hemorrhage, significant preexisting disability (mRS >1), severe comorbidities with life expectancy under 90 days, refractory hypertension, severe lower-limb injury that contraindicates RIC, or those enrolled in another experimental therapy may not receive benefit or may be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study applies remote ischemic conditioning (RIC)—brief, repeated cycles of limb ischemia and reperfusion using a blood pressure cuff—to patients with aneurysmal subarachnoid hemorrhage who have undergone craniotomy clipping. Eligible adults (18–80 years) who had clipping within 24 hours receive RIC in addition to guideline-based therapy, with safety and early efficacy outcomes recorded. The trial monitors adverse events related to RIC, hemodynamic stability, and short-term neurological and functional recovery measures. The single-site study at Beijing Tiantan Hospital aims to establish feasibility and provide preliminary data to inform larger trials.
Why it matters
Potential benefit: If successful, RIC could offer a low-cost, noninvasive way to reduce secondary brain injury and improve early recovery after aneurysm clipping.
How similar studies have gone: Remote ischemic conditioning has shown promise in some stroke and cardiac surgery studies, but its effectiveness specifically after aneurysmal subarachnoid hemorrhage and surgical clipping remains largely unproven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Imaging examination confirmed aneurysmal subarachnoid hemorrhage. 2. Responsible aneurysms received craniotomy clipping within 24 hours. 3. 18≤ age ≤80 years old. 4. Informed consent of the participant or legally authorized representative Exclusion Criteria: 1. Patients with other types of cerebral hemorrhage. 2. Prior neurological impairment (mRS Score \>1) or mental illness may confuse neurological or functional assessment. 3. Severe comorbidities with a life expectancy of less than 90 days. 4. Refractory hypertension (systolic blood pressure 180\>mmHg or diastolic blood pressure 110\>mmHg). 5. RIC contraindications: severe soft tissue injury of lower limbs. 6. Simultaneously participate in another research program to study a different experimental therapy. 7. Any condition that the investigator believes may increase the patient's risk.
Where it's running
-
Beijing Tiantan Hospital
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Aihua Liu, Doctor
- Email: liuaihuadoctor@ccmu.edu.cn
- Phone: +8615901398688
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intra-arterial clot-dissolving treatment for medium-vessel ischemic stroke
The team will test whether giving tenecteplase directly into the artery helps adults with acute ischemic stroke caused by medium-vessel blockage or severe narrowing.
-
Endovascular treatment for stroke beyond 24 hours
This study is testing whether a specific stroke treatment can help people who have had a stroke more than 24 hours ago feel better and regain independence compared to just receiving standard care.
-
Portable EEG to triage suspected stroke patients in ambulances
This trial will test whether a portable dry‑electrode EEG headset (StrokePointer) can detect large vessel occlusion strokes in adults with suspected acute stroke so ambulance crews can take them directly to hospitals that perform thrombectomy.
-
Video call assessment for suspected stroke
This study tests if using video calls between neurologists and emergency responders can help quickly and accurately assess patients who might be having a stroke.
-
Evaluating the impact of artery calcification on stroke treatment outcomes
This study is trying to see if the amount of calcium in the arteries affects how well stroke patients do after a specific treatment for blocked blood vessels.
-
Heart assessment to check repeat-stroke risk in people with atrial fibrillation
This project will test whether detailed heart examinations can find which people with atrial fibrillation who just had an ischemic stroke are at high risk of having another stroke.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.